Hiding in Plain Sight: The Utility of Genetic Testing in Common Forms of CKD
1:01:53
Hiding in Plain Sight: The Utility of Genetic Testing in Common Forms of CKD
ISN-KDIGO Webinar: KDIGO Workshop on the Nurse’s Role in Managing Symptoms of People on Dialysis
1:12:54
ISN-KDIGO Webinar: KDIGO Workshop on the Nurse’s Role in Managing Symptoms of People on Dialysis
Updates in IgA Nephropathy - Part 2 with Dr. Jürgen Floege
16:22
Updates in IgA Nephropathy - Part 2 with Dr. Jürgen Floege
Updates in IgA Nephropathy - Part 1 with Dr. Brad Rovin
15:19
Updates in IgA Nephropathy - Part 1 with Dr. Brad Rovin
Module 1 - Implementing Genetic Testing for CKD Webinar Series
1:02:32
Module 1 - Implementing Genetic Testing for CKD Webinar Series
KDIGO 2024 CKD Guidelines Unpacked: Hear it Straight from the Experts
1:36:16
KDIGO 2024 CKD Guidelines Unpacked: Hear it Straight from the Experts
IPNA-ISN-KDIGO Webinar - Contemporary Management of SSNS and SRNS: Latest Guidance from IPNA & KDIGO
1:11:23
IPNA-ISN-KDIGO Webinar - Contemporary Management of SSNS and SRNS: Latest Guidance from IPNA & KDIGO
APOL1 Controversies Conference Plenary Presentation: APOL1 Diagnostics and Therapeutics
29:12
APOL1 Controversies Conference Plenary Presentation: APOL1 Diagnostics and Therapeutics
APOL1 Controversies Conference Plenary: Patient & Caregiver Panel Discussion
42:18
APOL1 Controversies Conference Plenary: Patient & Caregiver Panel Discussion
APOL1 Controversies Conference Plenary: Ethics of Genetic Testing
32:20
APOL1 Controversies Conference Plenary: Ethics of Genetic Testing
APOL1 Controversies Conference Plenary: Epidemiology of APOL1 Kidney Disease
24:15
APOL1 Controversies Conference Plenary: Epidemiology of APOL1 Kidney Disease
APOL1 Controversies Conference Plenary: APOL1 Pathophysiology
36:17
APOL1 Controversies Conference Plenary: APOL1 Pathophysiology
Personalizing Our Approach: A Focus on Managing the Non-diabetic Patient in CKD
28:30
Personalizing Our Approach: A Focus on Managing the Non-diabetic Patient in CKD
KDIGO 2024 Guideline on Lupus Nephritis (LN): A Roundtable Discussion
45:33
KDIGO 2024 Guideline on Lupus Nephritis (LN): A Roundtable Discussion
KDIGO Scientific Symposium on the Impact of Viral Infection and the Role of Vaccines in Kidney Care
44:41
KDIGO Scientific Symposium on the Impact of Viral Infection and the Role of Vaccines in Kidney Care
KDIGO Heart Failure & Kidney Disease Conference Plenary: Patient Panel
37:20
KDIGO Heart Failure & Kidney Disease Conference Plenary: Patient Panel
KDIGO Heart Failure & CKD Conference Plenary: Prediction of Heart Failure in Patients with CKD
17:14
KDIGO Heart Failure & CKD Conference Plenary: Prediction of Heart Failure in Patients with CKD
KDIGO Heart Failure & Kidney Disease Conference Plenary: Interdisciplinary Care Models
36:19
KDIGO Heart Failure & Kidney Disease Conference Plenary: Interdisciplinary Care Models
KDIGO Heart Failure & Kidney Disease Conference Plenary: A New Era of GDMT
23:58
KDIGO Heart Failure & Kidney Disease Conference Plenary: A New Era of GDMT
KDIGO Heart Failure & Kidney Disease Conference Plenary: New AHA CKM Staging
24:03
KDIGO Heart Failure & Kidney Disease Conference Plenary: New AHA CKM Staging
KDIGO 2024 Guideline for Chronic Kidney Disease: Key Messages for Primary Care Physicians
5:31
KDIGO 2024 Guideline for Chronic Kidney Disease: Key Messages for Primary Care Physicians
KDIGO 2024 ANCA Vasculitis Guideline: Reading Between the Lines
46:01
KDIGO 2024 ANCA Vasculitis Guideline: Reading Between the Lines
61st ERA Congress Highlights on Complement-Mediated Kidney Disease with Marina Vivarelli
4:59
61st ERA Congress Highlights on Complement-Mediated Kidney Disease with Marina Vivarelli
61st ERA Congress Highlights on IgA Nephropathy with Jonathan Barratt
5:17
61st ERA Congress Highlights on IgA Nephropathy with Jonathan Barratt
A Contemporary Approach to Treatment of Anemia for Dialysis Patients: A KDIGO Perspective
1:01:46
A Contemporary Approach to Treatment of Anemia for Dialysis Patients: A KDIGO Perspective
Expert Roundtable Discussion on Dialysis-Related Amyloidosis (DRA)
33:32
Expert Roundtable Discussion on Dialysis-Related Amyloidosis (DRA)
Dialysis-Related Amyloidosis (DRA): We Still Have a Long Way to Go
12:54
Dialysis-Related Amyloidosis (DRA): We Still Have a Long Way to Go
Dialysis-Related Amyloidosis: A Perspective from the US
4:27
Dialysis-Related Amyloidosis: A Perspective from the US
Pathophysiology of Dialysis-Related Amyloidosis: B2-Microglobulin-Related Amyloid Fibril Formation
5:11
Pathophysiology of Dialysis-Related Amyloidosis: B2-Microglobulin-Related Amyloid Fibril Formation
KDIGO 2024 Guideline on ANCA-Associated Vasculitis: Update on Current Management and Treatment
44:12
KDIGO 2024 Guideline on ANCA-Associated Vasculitis: Update on Current Management and Treatment